Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2006.05.030 Byline: Simon de Denus (a)(b), Jean-Claude Tardif (c), Michel White (c), Martial G. Bourassa (c), Normand Racine (c), Sylvie Levesque (d), Anique Ducharme (c) Abstract: Limited data are available to predict the occurrence of hyperkalemia. Risk assessment is complicated by the lack of consistency of definition between trials. Author Affiliation: (a) Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada. (b) Department of Pharmacy, Montreal Heart Institute, Montreal, Quebec, Canada (c) Department of Medicine , Montreal Heart Institute, Montreal, Quebec, Canada (d) Department of Biostatistics, Montreal Heart Institute, Montreal, Quebec, Canada Article History: Received 12 November 2004; Accepted 2 May 2006 Article Note: (footnote) Drs Ducharme and White were supported by the Fonds de recherche en sante du Quebec., Dr Tardif holds the Pfizer and Canadian Institutes of Health Research chair in atherosclerosis.